PPQ analogues are a new class of novel anti-influenza agents.
PPQ analogues inhibit cytoplasmic trafficking of influenza ribonucleoprotein (RNP).
PPQ inhibits viral protein synthesis at the beginning of H1N1 infection.
PPQ blocks the RNP nuclear export and aggregation in cytoplasm at later times.
PPQ interacts to RNP at a distinct NP site different than nucleozin.